Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Cancer Lett. 2017 Apr 25;400:110–116. doi: 10.1016/j.canlet.2017.04.019

Figure 2.

Figure 2

TAK228 suppressed DIPG proliferation and enhanced radiosensitization

A) Representative 400× photomicrographs showing decreased proliferation as measured by BrdU immunofluorescence (red) after treatment with 25 nM TAK228 for 3 days followed by 2 Gy radiation. DAPI counterstains nuclei (blue). B) Quantification of DIPG proliferation after TAK228 and radiation treatment ***: p <0.0001, **: p <0.01, *: p <0.05 vs. DMSO by t-test.